Substituted estratriene derivatives as 17BETA HSD inhibitors

Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17 -hydroxysteroid dehydrogenase (17 -HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical c...

Full description

Saved in:
Bibliographic Details
Main Authors MESSINGER JOSEF, THOLE HEINRICH-HUBERT, KOSKIMIES PASI, SCHOEN UWE, HUSEN BETTINA, UNKILA MIKKO
Format Patent
LanguageEnglish
Published 16.10.2012
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17 -hydroxysteroid dehydrogenase (17 -HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Bibliography:Application Number: US20070947025